Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prediction of Immune-related Adverse Events Induced by Anti-CTLA4 and Anti-PD1/PDL1 Drugs by Means of a Battery of Autoantibodies. a Multicenter Prospective Observational Cohort Study

NCT03868046 is registered in ClinicalTrials.gov with Hospital Universitario Araba as lead sponsor.

NCT NCT03868046
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03868046 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prediction of Immune-related Adverse Events Induced by Anti-CTLA4 and Anti-PD1/PDL1 Drugs by Means of a Battery of Autoantibodies. a Multicenter Prospective Observational Cohort Study
Lead sponsor
Hospital Universitario Araba
Phase
Observational
Overall status
Completed
Start date
August 25, 2019
Completion date
December 31, 2023
Enrollment
242 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, metastatic cancer, solid organ cancer